Human PRPS1 and PRPS2 gene products are implicated in drug resistance associated with recurrent acute lymphoblastic leukaemia and progression of colorectal cancer and hepatocellular carcinoma. This evidence concerns the gene PRPS1 and acute lymphoblastic leukemia.